AI-generated summary
The authors pooled 15 randomised controlled trials with 883 patients to assess bright light therapy for non-seasonal major depressive disorder. They report that bright light therapy was associated with a moderate reduction in depressive symptoms compared with control, with stronger effects in shorter trials and with 60 or more minutes of daily exposure.
- Participants
- 883
- Studies included
- 15
- Who or what was studied
- Patients with non-seasonal major depressive disorder enrolled in randomised controlled trials
- Limits stated in the abstract
- The abstract does not report the wavelengths or device specifications used, and the evidence comes from a meta-analysis of a relatively small number of trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Meta-analysis, Bright light therapy, Systematic review, Light-emitting diode, Primary outcome, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.